A Two-Compartment Description and Kinetic Procedure for Measuring Regional Cerebral [11C]Nomifensine Uptake Using Positron Emission Tomography
- 1 May 1990
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 10 (3) , 307-316
- https://doi.org/10.1038/jcbfm.1990.59
Abstract
S-[11C]Nomifensine ( S-[11C]NMF) is a positron-emitting tracer suitable for positron emission tomography, which binds to both dopaminergic and noradrenergic reuptake sites in the striatum and the thalamus. Modelling of the cerebral distribution of this drug has been hampered by the rapid appearance of glucuronide metabolites in the plasma, which do not cross the blood–brain barrier. To date, [11C]NMF uptake has simply been expressed as regional versus nonspecific cerebellar activity ratios. We have calculated a “free” NMF input curve from red cell activity curves, using the fact that the free drug rapidly equilibrates between red cells and plasma, while glucuronides do not enter red cells. With this free [11C]NMF input function, all regional cerebral uptake curves could be fitted to a conventional two-compartment model, defining tracer distribution in terms of [11C]NMF regional volume of distribution. Assuming that the cerebellar volume of distribution of [11C]NMF represents the nonspecific volume of distribution of the tracer in striatum and thalamus, we have calculated an equilibrium partition coefficient for [11C]NMF between freely exchanging specific and nonspecific compartments in these regions, representing its “binding potential” to dopaminergic or noradrenergic uptake sites (or complexes). This partition coefficient was lower in the striatum when the racemate rather than the active S-enantiomer of [11C]NMF was administered. In the striatum of patients suffering from Parkinson's disease and multiple-system atrophy, the specific compartmentation of S-[11C]NMF was significantly decreased compared with that of age-matched volunteers.Keywords
This publication has 17 references indexed in Scilit:
- Synthesis of racemic (+) and (−) N-[methyl-11C]nomifensine, a ligand for evaluation of monoamine re-uptake sites by use of positron emission tomographyInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1989
- Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's diseaseNature, 1988
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988
- Monoamine re-uptake sites in the human brain evaluatedin vivoby means of11C-nomifensine and positron emission tomography: the effects of age and Parkinson's diseaseActa Neurologica Scandinavica, 1988
- In vivoevaluation of striatal dopamine reuptake sites using 11C-nomifensine and positron emission tomographyActa Neurologica Scandinavica, 1987
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. GeneralizationsJournal of Cerebral Blood Flow & Metabolism, 1985
- Quantitative autoradiography of 3H-nomifensine binding sites in rat brainLife Sciences, 1985
- A New Headholder for PET, CT, and NMR ImagingJournal of Computer Assisted Tomography, 1984
- A quantitative model for the in vivo assessment of drug binding sites with positron emission tomographyAnnals of Neurology, 1984
- Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical EffectsJournal of Computer Assisted Tomography, 1981